As the second quarter gets underway, April stands out for both global health awareness - from Cancer Control Month to World Health Day on April 7 - and a fresh wave of regulatory catalysts. Here's a look at the upcoming FDA decisions scheduled for April.Biogen Inc. (BIIB) Biogen has sought FDA approval for a higher-dose regimen of SPINRAZA for spinal muscular atrophy, and a decision is expected on...
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.